3M executive exercises options, sells 7,669 shares

3M executive Kevin H. Rhodes, EVP and Chief Legal Officer, reported exercising a non-qualified stock option for 7,669 shares of common stock on July 22, 2026 at an exercise price of $154.6900 per share.

Rhea-AI Filing Summary

3M executive Kevin H. Rhodes, EVP and Chief Legal Officer, reported exercising a non-qualified stock option for 7,669 shares of common stock on July 22, 2026 at an exercise price of $154.6900 per share. He then sold 7,669 shares of common stock at $171.2000 per share the same day. The option, originally granted on February 7, 2018 and expiring February 6, 2027, now shows zero remaining derivative shares, and the transactions were not made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Exercise and Sale: 7,669 shares ($127K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Rhodes Kevin H

Role EVP, Chief Legal Off & Secret

Sold 7,669 shs ($1.31M)

Approx. gross sale proceeds $1.31M

Approx. exercise cost $1.19M

Approx. pre-tax spread $127K

Type	Security	Shares	Price	Value
Exercise	Non-qualified Stock Option (Right to Buy)	7,669	$0.00	$0.00
Exercise	Common Stock	7,669	$154.69	$1.19M
Sale	Common Stock F1	7,669	$171.20	$1.31M

Holdings After Transaction: Non-qualified Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 43,779.9933 shares (Direct)

Footnotes (1)

1. F1. Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.

Key Figures

Options exercised: 7,669 shares Exercise price: $154.6900 per share Common shares sold: 7,669 shares +4 more

7 metrics

Options exercised 7,669 shares Non-qualified stock option exercised on July 22, 2026

Exercise price $154.6900 per share Exercise price of the non-qualified stock option

Common shares sold 7,669 shares Common stock sold on July 22, 2026

Sale price $171.2000 per share Per-share price for the reported common stock sale

Option grant date February 7, 2018 Grant date of the exercised non-qualified stock option

Option expiration February 6, 2027 Expiration date associated with the exercised option grant

Net shares sold 7,669 shares Net sell direction across reported Form 4 transactions

Key Terms

Non-qualified Stock Option (Right to Buy), Deferred Compensation Plan, dividend share equivalents

3 terms

Non-qualified Stock Option (Right to Buy) financial

"Security title listed as Non-qualified Stock Option (Right to Buy)"

Deferred Compensation Plan financial

"pursuant to 3M's Deferred Compensation Plan"

A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.

dividend share equivalents financial

"Includes dividend share equivalents, accrued quarterly"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did 3M (MMM) executive Kevin H. Rhodes report?

Kevin H. Rhodes reported exercising 7,669 non-qualified stock options and selling 7,669 shares of 3M common stock. Both the option exercise and the share sale occurred on July 22, 2026, according to the Form 4 insider filing.

At what prices did Kevin H. Rhodes exercise and sell 3M (MMM) shares?

Rhodes exercised options at an exercise price of $154.6900 per share and then sold 7,669 3M common shares at $171.2000 per share. These prices are reported on the Form 4 for the July 22, 2026 transactions.

How many 3M (MMM) options did Kevin H. Rhodes exercise in this Form 4?

He exercised a non-qualified stock option covering 7,669 shares of 3M common stock. The option was originally granted on February 7, 2018 and carried an expiration date of February 6, 2027 before being fully exercised.

Were Kevin H. Rhodes’s 3M (MMM) transactions under a Rule 10b5-1 plan?

The filing indicates the transactions were not made pursuant to a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is explicitly unchecked, meaning no pre-arranged trading plan is affirmed for these reported trades.

What does the Form 4 say about remaining 3M (MMM) options after Rhodes’s exercise?

The non-qualified stock option for 7,669 shares shows 0 derivative shares remaining after the July 22, 2026 exercise. This indicates the reported option grant tied to these transactions has been fully exercised and no longer represents an outstanding derivative position.

What does the footnote about dividend share equivalents mean for 3M (MMM)?

A footnote explains that certain reported holdings include dividend share equivalents accrued quarterly under 3M’s Deferred Compensation Plan. These equivalents track dividends on deferred amounts but are described separately from the main option exercise and share sale figures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/23/2026 - 04:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rhodes Kevin H

(Last) (First) (Middle)

3M CENTER

(Street)

ST. PAUL MINNESOTA 55144-1000

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
3M CO [ MMM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Off & Secret

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/22/2026		M		7,669	A	$154.69	51,448.9933	D
Common Stock	07/22/2026		S		7,669	D	$171.2	43,779.9933(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$154.69	07/22/2026		M			7,669	02/07/2018	02/06/2027	Common Stock	7,669	$0	0	D

Explanation of Responses:

1. Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.

	Patricia L. Meagher, attorney-in-fact for Kevin H. Rhodes	07/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)